Last week, The Pathologist released their 2020 Power List which celebrates influential figures, thought leaders and opinion shapers in pathology and laboratory medicine.

For the second year in a row, Anant Madabhushi, PhD, the F. Alex Nason Professor II of Biomedical Engineering, professor of pathology and Director of the Center for Computational Imaging and Personalized Diagnostics at CWRU, was named to the list. Dr. Madabushi is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program and Chair of the Artificial Intelligence in Oncology Symposium Planning Committee. Congratulations, Dr. Madabhushi!

A recent article published in Cancer Discovery (Bayik, 2020, Cancer Discov) highlights disparities in immune system functions between male and female glioblastoma patients that may underlie some of the observed sex differences in cancer incidence, prognosis and treatment response. Defne Bayik, PhD a postdoctoral fellow in Justin Lathia, PhD's lab at Cleveland Clinic Lerner Research Institute, and colleagues from Cleveland Clinic, Case Western Reserve University, University Hospitals, The University of Southern Denmark, Moffitt Cancer Center, and Northwestern University found that monocytic myeloid-derived suppressor cells (MDSC) were enriched in the tumors of male mice, but not female mice. The findings of the work reveal a previously unknown explanation for sex differences in glioblastoma and demonstrates how this knowledge may be therapeutically exploitable. Case Comprehensive Cancer Center members Ahmad Khalil, PhD, Tae Hyun Hwang, PhD, Manmeet Ahluwalia, MD, Feixiong Cheng, PhD, and Justin Lathia, PhD also contributed to the work.

This October, Geraldine McGinty, MD, MBA, FACR, Chief Contracting and Strategy Officer and Assistant Professor of Radiology, Health Care Policy and Research at Weill Cornell Medicine will deliver the plenary address of the 2020 Artificial Intelligence in Oncology Symposium. Her talk is titled, "Fostering a Strong Ecosystem for AI in Medical Imaging."

Dr. McGinty is an internationally recognized expert in imaging economics whose published work has focused on payment models for imaging, most recently a bundled payment for breast cancer screening. Recently, she has focused on the impact of Artificial Intelligence on Medical Imaging and has spoken at the Turing Institute and to the WHO Focus Group on AI in Healthcare on this topic.

Additional symposium keynotes on drug discovery, ethics & policy and pathology will be delivered by Russ Altman, MD, PhD of Stanford University, Aashima Gupta, MS of Google, Vinay Prasad, MD, MPH of the University of California, San Francisco, and Yinyin Yuan, PhD of the Institute of Cancer Research, London.

The Case Comprehensive Cancer Center is now accepting applications for the Fall 2020 pilot funding opportunities:

Questions? Contact casecccpilots@case.edu or Julie DeJager Glavic at 216.368.5780.

The American Lung Association (ALA) nationwide research program is building on over a century of success as we continue to invest in the brightest, pioneering minds with immense potential to drive innovation, discover the unknown, and improve the lives of those living with lung cancer. The Lung Cancer Discovery Award is for highly meritorious research projects with the potential to:

This award, for $100,000 per year for up to two years, is intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods.